Switzerland's Siegfried Holding says that a significant jump in
2007 net profit, up 54 per cent to CHF 49.7m ($50m), vindicates its
decision to refocus on the active pharmaceutical ingredients and
generics sector.
Altana Chemie, the specialty chemicals unit of German
pharmaceutical and chemicals company Altana, has said it plans to
acquire Eckart for €630 million in cash, in what is the largest
purchase in the company's history.
Italy's Recordati has reported flat turnover but a rise in
operating income in 2004, while its pharmaceutical chemicals
business managed to return to profit, reports Phil Taylor.
BASF and Merck KGaA have joined DSM in reporting encouraging
first-quarter 2004 results, raising hopes further that the European
chemicals sector may be about to move into recovery mode, writes
Phil Taylor.
German contract ingredient manufacturer Girindus posted its first
profit since it was floated on the stock exchange in 2000 in the
last quarter of 2003, as sales rose 16 per cent to €32 million.
Bayer has reported a decline in net profits for the second quarter
of 2003, with analysts expressing concerns that litigations costs
could hold back full-year earnings.